Primary sclerosing cholangitis: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(20 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
{{DiseaseDisorder infobox |
{{DiseaseDisorder infobox |
   Name        = Primary sclerosing cholangitis |
   Name        = Primary sclerosing cholangitis |
Line 7: Line 8:
'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''
'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''


{{CMG}}
{{CMG}}; {{AE}}{{DN}}
==Overview==


==Signs and symptoms==
{{SK}} PSC; primary sclerosing cholangitis
==[[Primary sclerosing cholangitis overview|Overview]]==


==Diagnosis==
==[[Primary sclerosing cholangitis historical perspective|Historical Perspective]]==


==Etiology==
==[[Primary sclerosing cholangitis classification|Classification]]==
The cause(s) for PSC are unknown. It is often considered to be an [[autoimmunity|autoimmune disorder]]. PSC is associated with [[ulcerative colitis]]. It is assumed that these diseases share a common cause.


Ulcerative colitis is a systemic disease that affects many areas of the body. PSC is often listed as a manifestation of ulcerative colitis outside the colon. PSC differs from these manifestations in that, unlike most other manifestations, PSC continues in spite of surgical removal of the colon.[http://www.acg.gi.org] This suggests that, while the cause of ulcerative colitis, and most of its manifestations, is in the colon, the cause of PSC is located outside the colon.
==[[Primary sclerosing cholangitis pathophysiology|Pathophysiology]]==


==Pathophysiology==
==[[Primary sclerosing cholangitis causes|Causes]]==
Bile ducts, both intra- and extrahepatically (inside the liver and outside), are inflamed and develop scarring, obstructing the flow of bile. As bile assists in the enteric breakdown and absorption of fat, the absence of bile leads to fat malabsorption. The bile accumulates in the duct, leading to liver cell damage and liver failure.


==Epidemiology==
==[[Primary sclerosing cholangitis differential diagnosis|Differentiating Primary sclerosing cholangitis from other Diseases]]==
It is more prevalent in men than in women. The disease normally starts from age 30 to 60. It can however also start with children. PSC progresses slowly, so the [[disease]] can be active for a long time before it is noticed or diagnosed.


==Screening==
==[[Primary sclerosing cholangitis epidemiology and demographics|Epidemiology and Demographics]]==
PSC is associated with [[cholangiocarcinoma]], which are tumors involving the biliary tree.  Screening for cholangiocarcinoma in patients with PSC is encouraged, but there is no general consensus on the modality and interval of choice.


==Therapy==
==[[Primary sclerosing cholangitis risk factors|Risk Factors]]==
Standard treatment includes [[ursodiol]], a bile acid naturally produced by the liver, which has been shown to lower elevated liver enzyme numbers in people with PSC, but has not yet been proven effective at prolonging the life of the liver.  Treatment also includes medication to relieve itching ([[antipruritic]]s) and bile acid sequesterants (cholestyramine), [[antibiotic]]s to treat infections, and [[vitamin]] supplements, as people with PSC are often deficient in [[vitamin A]], [[vitamin D]], and [[vitamin K]].


In some cases, ERCP, which may involve stenting of the common bile duct, may be necessary in order to open major blockages (dominant strictures).
==[[Primary sclerosing cholangitis screening|Screening]]==


[[Liver transplantation]] (including live transplants whereby a portion of a living donor is given to the recipient) is an option if the liver begins to fail.
==[[Primary sclerosing cholangitis natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
 
==[[Primary sclerosing cholangitis diagnosis|Diagnosis]]==
[[Primary sclerosing cholangitis history and symptoms|History and Symptoms]] | [[Primary sclerosing cholangitis physical examination|Physical Examination]] | [[Primary sclerosing cholangitis laboratory findings|Laboratory Findings]] | [[Primary sclerosing cholangitis electrocardiogram|Electrocardiogram]] | [[Primary sclerosing cholangitis x ray|X Ray]] | [[Primary sclerosing cholangitis CT|CT]] | [[Primary sclerosing cholangitis MRI|MRI]] | [[Primary sclerosing cholangitis ultrasound|Ultrasound]] | [[Primary sclerosing cholangitis other imaging findings|Other Imaging Findings]] | [[Primary sclerosing cholangitis other diagnostic studies|Other Diagnostic Studies]]
 
==Treatment==
[[Primary sclerosing cholangitis medical therapy|Medical Therapy]] | [[Primary sclerosing cholangitis surgery|Surgery]] | [[Primary sclerosing cholangitis primary prevention|Primary Prevention]] | [[Primary sclerosing cholangitis secondary prevention|Secondary Prevention]] | [[Primary sclerosing cholangitis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Primary sclerosing cholangitis future or investigational therapies|Future or Investigational Therapies]]
 
==Case Studies==
 
[[Primary sclerosing cholangitis case study one|Case #1]]


== See also ==
== See also ==
Line 43: Line 49:
* [[Alagille syndrome]]
* [[Alagille syndrome]]
* [[Progressive familial intrahepatic cholestasis]]
* [[Progressive familial intrahepatic cholestasis]]
* Walter Payton (died of primary sclerosing cholangitis)


== External links ==
== External links ==
Line 54: Line 59:
{{Gastroenterology}}
{{Gastroenterology}}


[[Category:Autoimmune diseases]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Hepatology]]
[[Category:Hepatology]]
[[Category:Inflammations]]


[[de:Cholangitis]]
[[de:Cholangitis]]

Latest revision as of 18:16, 12 December 2016

Template:DiseaseDisorder infobox

Primary sclerosing cholangitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Primary sclerosing cholangitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Primary sclerosing cholangitis On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Primary sclerosing cholangitis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Primary sclerosing cholangitis

CDC on Primary sclerosing cholangitis

Primary sclerosing cholangitis in the news

Blogs on Primary sclerosing cholangitis

Directions to Hospitals Treating Primary sclerosing cholangitis

Risk calculators and risk factors for Primary sclerosing cholangitis

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2]

Synonyms and keywords: PSC; primary sclerosing cholangitis

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Primary sclerosing cholangitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

See also

External links

Template:Gastroenterology

de:Cholangitis sv:Primär skleroserande kolangit


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Primary_sclerosing_cholangitis&oldid=1275474"